| Today, Mon, Nov 9, 2009 | | • | Top 10 Stocks for Obamacare
at CNBC (Mon 8:25am)
| | • | U.S. Healthcare Legislation Investment Impact
at Seeking Alpha (Mon 5:07am)
| | • | [video] Practicing Balance With P&G: China Watch
at TheStreet.com (Mon 5:00am)
| | Sat, Nov 7, 2009 | | • | Elan, Biogen change Tysabri label due to PML risk
at Reuters (Sat, Nov 7)
| | Thu, Nov 5, 2009 | | • | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Alnylam takes wider loss on administrative costs
AP (Wed, Nov 4)
| | • | 4-Star Stocks on the Upswing
at Motley Fool (Wed, Nov 4)
| | • | Trading Outlook for MannKind Corp. Issued by InvestorSoup.com
GlobeNewswire (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | Nice Quarter, Teva. What Will You Buy Next?
at Motley Fool (Tue, Nov 3)
| | • | 10 Stocks Shaking the Market
at Motley Fool (Tue, Nov 3)
| | • | Obamacare Positive To Net Neutral For Pharmaceutical Industry According To Analysis By Morningstar Expert
Wall Street Transcript (Tue, Nov 3)
| | • | [$$] Biogen's a Buy
at Barrons.com (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Finally Convinced? Benlysta Works!
at Motley Fool (Mon, Nov 2)
| | • | CEO Interview: China Sky One Medical, Inc. - Yan-Qing Liu and Stanley Hao
Wall Street Transcript (Mon, Nov 2)
| | • | Medicines Co. Misses & Cuts
Zacks.com (Mon, Nov 2)
| | • | Human Genome Calls Second Lupus Drug Study a Success
at TheStreet.com (Mon, Nov 2)
| | • | Biogen Idec upgraded by Jefferies & Co
Briefing.com (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | • | Earnings? Yawn. Trial Data? Moving!
at Motley Fool (Fri, Oct 30)
| | • | Don't Make This Humongous Life-Wrecking Error
at Motley Fool (Fri, Oct 30)
| | • | Healthcare Profits: Rating Company Sensitivity to Obamacare
at Seeking Alpha (Fri, Oct 30)
|
Add BIIB News to My Yahoo!:
 
| |
|
2.03% Nasdaq 
0.35 (0.76%) 
Headlines
